צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים: heartbeam.com (BEAT)

HeartBeam, Inc. (BEAT) success is based on the implementation of mobile 3D-ECG systems and FDA approval. This trailing twelve-month revenue chart reflects the dynamics of this process, where the current value is 0.00. A team of top-tier engineers is creating life-saving tools, while unique patents for myocardial infarction diagnostics form a technological foundation that will strengthen upon mass adoption by physicians.
HeartBeam Inc (BEAT) - פילוחי מדדים ודוחות פיננסיים

This metric measures revenue dynamics over the last twelve months relative to the same period last year, revealing the business's operational resilience to demand fluctuations. By analyzing this rolling year-over-year revenue growth chart, one can assess the commercialization of HeartBeam, Inc. (BEAT) ECG systems following FDA approvals. The positive trend confirms the successful implementation of telemedicine solutions within hospital networks, while steady growth guarantees investors a capital safety margin.